EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 359 filers reported holding EXELIXIS INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95,856 | -46.1% | 4,387 | -52.9% | 0.02% | -59.6% |
| Q2 2023 | $177,857 | -35.1% | 9,307 | -34.0% | 0.05% | -40.9% |
| Q1 2023 | $273,895 | -32.2% | 14,111 | -43.9% | 0.09% | -34.3% |
| Q4 2022 | $403,807 | +208.2% | 25,175 | +200.5% | 0.13% | +106.2% |
| Q3 2022 | $131,000 | +4.8% | 8,378 | +39.7% | 0.06% | -15.6% |
| Q2 2022 | $125,000 | +71.2% | 5,996 | +50.7% | 0.08% | +126.5% |
| Q4 2021 | $73,000 | -1.4% | 3,978 | +14.0% | 0.03% | -29.2% |
| Q3 2021 | $74,000 | – | 3,488 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |